Nurocor provides a digital protocol platform that converts clinical trial protocols into a machine‑readable, standards‑compliant format, serving as a single source of truth for the entire study lifecycle. By integrating directly with systems such as EDC, labs, eCOA, and IRT and using AI‑assisted authoring, the solution eliminates manual translation errors, reduces amendment rates, and accelerates site activation, delivering over 20% cost and time savings per trial.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trial protocols are still created as static, paper-based documents, requiring manual interpretation and repeated translation across disparate systems. This leads to costly protocol amendments, slow study start‑up, inconsistent data standards, and operational delays that extend development timelines and increase expenses.
Solution
Nurocor digitizes clinical trial protocols into a structured, machine‑readable format that serves as a single source of truth for the entire study lifecycle. By conforming to industry standards such as CDISC and embedding regulatory requirements, the platform enables downstream systems—including EDC, labs, eCOA, and IRT—to consume protocol content directly, eliminating manual translation errors. AI‑driven design tools automate protocol structuring and standards governance, while a parallel, digital workflow replaces the traditional serial paper process. The result is faster site activation, reduced amendment rates, and overall study duration and cost savings of more than 20% per trial.
Target Audience
Primary customers are pharmaceutical companies and contract research organizations that design, manage, and execute clinical trials, particularly those seeking to streamline protocol development and reduce study timelines.
Features
- Machine‑readable digital protocol format that integrates with all major clinical trial systems
- AI‑assisted protocol authoring that automatically structures content and aligns with CDISC and regulatory standards
- Intelligent standards governance engine that continuously validates compliance across the study lifecycle
- Parallel, digital workflow (Lean Protocol™) that accelerates study start‑up and reduces manual hand‑offs
- Real‑time change propagation to prevent costly protocol amendments and ensure consistent data definitions
- Single source of truth architecture that eliminates translation errors between design and execution teams